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world as the founder of the Rho GTPase
signaling field, which has had a huge
impact on many areas of research, from
animal and plant development to cancer
progression. He sadly died suddenly of
a heart attack while out jogging in
New York City on May 3, 2015. He was
62 and seemed fit and well. He was very
active in his research, as well as in his
new role as Editor-in-Chief of the Journal
of Cell Biology.
Alan was born in Yorkshire in the UK
in 1952. He studied chemistry at the Uni-
versity of Oxford, taking a few courses in
biochemistry. He started his PhD studies
there in chemistry but soon moved to
Boston with his PhD supervisor Jeremy
Knowles, graduating in 1977. Alan moved
back to the UK and then to Switzerland
for two short postdocs, during which he
learned the techniques of molecular
biology. He was recruited as a young
group leader to the Institute of Cancer
Research in London in 1981 by then
Director, Robin Weiss. There, he started
working with Chris Marshall on a long and
productive collaboration. Together, they
discovered and cloned the third Ras
oncogene, N-Ras. They published a series
of highly influential papers characterizing
the biochemical properties and cellular
functions of N-Ras.
In the late 1980s, Alan turned his atten-
tion to the Rho cDNAs that Chris had
obtained but were sitting untouched in
a freezer. Alan combined his chemistry,
biochemistry, molecular biology, and
newly developed cell biology skills to
study Rho family proteins. He published
his first paper on Rho, showing that
Rho induced cell shape changes, in
1990. This opened up a whole new field
of research. When I arrived in his labo-
ratory in 1990, this was a field ripe for
growth. It was a really exciting time
at the Institute of Cancer Research. Chris
Marshall’s laboratory was identifying
kinases downstream of Ras. Alan purified
and characterized the first RhoGAP and
realized that it had homology to a region
of Bcr, which is fused to Abl in leukemias.
This led to the identification of a huge
family of Rho GAPs. We worked together
to demonstrate that Rho and Rac were504 Reprinted from Cell 161, June 4, 2015 ª2essential for extracellular signals to
induce changes to the actin cytoskeleton
and to coordinate cell migration.
In 1993, Alan moved to the newly
formed MRC Laboratory of Molecular
Cell Biology (LMCB) at University College
London, which was started up by Colin
Hopkins. He took over as head of
the LMCB in 2001. Having convinced the
MRC to give a lot more money to the
LMCB, he hired excellent young group
leaders, increased the PhD program size,
and bought a top-class coffee machine.
He created a strong and successful insti-
tute and balanced this admirably with a
highly productive laboratory. At the
LMCB, he recruited and worked with a
series of excellent postdocs. For example,
he worked with Kate Nobes to determine
the function of Cdc42 in inducing filopo-
dia, with Emmanuelle Caron to describe
the roles of Rho GTPases in different
types of phagocytosis, and with Sandrine
Etienne-Manneville to show how Cdc42
and the Par polarity complex regulated
polarized cell migration. Alan also
wrote a series of influential and insightful
reviews on Rho GTPase signaling with
members of his laboratory.
Alan’s talents were spotted by Memo-
rial Sloan-Kettering Cancer Center in
New York, and the London community
sadly bid him farewell in 2006, when he
moved to Sloan-Kettering as Chair of the
Cell Biology Program. He expanded the
cell biology program by recruiting several
excellent new team leaders, leaving a015 Elsevier Inc.strong program behind him. Alan’s
research in New York focused on roles
of Rho GTPase signaling in epithelial
polarity and collective cell migration. In a
recent paper, he moved for the first time
into in vivo studies on collective cell
migration. This promised to be the start
of a new area of research for him.
I firstmetAlanwhen I gave a short talk as
a PhD student, working on Ras, at a
meeting in the UK. Alan was chairing the
session, and he asked me questions at
the end that showed genuine interest in
my results, not just because he was
the session chair. This epitomized his
character as a scientist—Alan touched so
many scientists’ lives by listening to them
and taking a real interest in their results.
At conferences, Alan went to posters and
talks, asked insightful and constructive
questions, and gave helpful advice. Alan
was always generous with his time and
with reagents, which he shared freely.
As a group leader, Alan was an inspira-
tional mentor. He treated everyone in the
laboratory equally and gave his postdocs
the freedom to work on the projects they
wanted to—they brought in their own
model systems or chose their project
based on previous results from the labo-
ratory. Whatever the project, Alan sup-
ported us to achieve our best. He valued
our ideas and input into the projects.
This created a great atmosphere in the
lab, where everyone helped each other,
because nobody was in competition. He
has left a big lab family, many of whom
have gone on to be successful group
leaders. We have all been influenced by
his style of leadership: he was interested
in everybody andwent through our results
carefully and thoroughly, discussing
future experiments in a way that made
sure we felt we owned them.
Alan was an editor for the Journal of
Cell Biology for 20 years. Anybody who
had their paper handled by Alan will
remember his constructive and careful
analysis of the reviewers’ points, bringing
out what was important to address and
indicating what could politely be ignored.
Alan’s research eminence was recognized
through his elections as a member of the
European Molecular Biology Organization
in1995andasaFellowof theRoyalSociety
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Biochemical Society) in 2005, the Louis
Jeantet Prize for Medicine in 2006, and
the Canada Gairdner Prize in 2009.
The last time that I sawAlanwas at a cell
biology conference in Brazil, at which he
was in fine form. We discussed everythingfrom Rho mutations in gastric cancers to
our children’s career moves. Alan’s sud-
den and tragic death has taken away an
influential, generous, and kind leader in
the field of cell signaling and GTPases.
He leaves behind his wife Eileen, his
daughter and son, and two grandchildren.Reprinted from CellAnne Ridley1,*
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